| Primary |
| Product Used For Unknown Indication |
63.9% |
| Hypertension |
17.1% |
| Cardiac Failure Chronic |
3.2% |
| Drug Use For Unknown Indication |
2.5% |
| Cardiac Failure |
1.9% |
| Myxoedema |
1.9% |
| Anxiety |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Blood Pressure Abnormal |
1.3% |
| Depression |
1.3% |
| Psychotic Disorder |
1.3% |
| Back Pain |
0.6% |
| Blood Pressure |
0.6% |
| Hypercholesterolaemia |
0.6% |
| Hypersensitivity |
0.6% |
| Panic Attack |
0.6% |
|
| Atrial Fibrillation |
13.3% |
| Hyperkalaemia |
10.0% |
| Pharmaceutical Product Complaint |
10.0% |
| Renal Failure |
6.7% |
| Swollen Tongue |
6.7% |
| Therapeutic Response Unexpected With Drug Substitution |
6.7% |
| Acute Pulmonary Oedema |
3.3% |
| Angioedema |
3.3% |
| Blood Pressure Fluctuation |
3.3% |
| Completed Suicide |
3.3% |
| Death |
3.3% |
| Dehydration |
3.3% |
| Dizziness |
3.3% |
| Drug Dispensing Error |
3.3% |
| Gastric Ulcer Haemorrhage |
3.3% |
| Gastroenteritis |
3.3% |
| Hypertension |
3.3% |
| Lip Oedema |
3.3% |
| Loss Of Consciousness |
3.3% |
| Medication Error |
3.3% |
|
| Secondary |
| Hypertension |
30.0% |
| Product Used For Unknown Indication |
12.3% |
| Diabetes Mellitus |
6.8% |
| Cerebral Toxoplasmosis |
5.9% |
| Renal Failure |
5.9% |
| Type 2 Diabetes Mellitus |
4.5% |
| Cardiac Failure |
4.1% |
| Drug Use For Unknown Indication |
4.1% |
| Gastritis |
3.2% |
| Thrombosis |
3.2% |
| Atrial Fibrillation |
2.7% |
| Cardiac Failure Chronic |
2.7% |
| Heart Rate Increased |
2.7% |
| Ill-defined Disorder |
2.7% |
| Depression |
2.3% |
| Anaemia |
1.4% |
| Antiplatelet Therapy |
1.4% |
| Asthma |
1.4% |
| Cardiac Disorder |
1.4% |
| Diuretic Effect |
1.4% |
|
| Renal Failure Acute |
17.3% |
| Neutropenia |
11.5% |
| Death |
7.7% |
| Completed Suicide |
5.8% |
| Urine Output Decreased |
5.8% |
| Agranulocytosis |
3.8% |
| Blood Pressure Systolic Increased |
3.8% |
| Convulsion |
3.8% |
| Headache |
3.8% |
| Hypotension |
3.8% |
| Nephritic Syndrome |
3.8% |
| Pancreatitis Acute |
3.8% |
| Paraesthesia |
3.8% |
| Poisoning |
3.8% |
| Renal Tubular Disorder |
3.8% |
| Unresponsive To Stimuli |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Blood Pressure Fluctuation |
1.9% |
| Blood Pressure Increased |
1.9% |
| Bradyarrhythmia |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.7% |
| Hypertension |
15.3% |
| Drug Use For Unknown Indication |
14.3% |
| Prophylaxis |
4.1% |
| Type 2 Diabetes Mellitus |
3.3% |
| Colon Cancer |
2.9% |
| Acute Myocardial Infarction |
2.6% |
| Rheumatoid Arthritis |
2.6% |
| Atrial Fibrillation |
2.5% |
| Insomnia |
2.4% |
| Pain |
2.2% |
| Diabetes Mellitus |
2.0% |
| Hypercholesterolaemia |
1.7% |
| Hepatitis C |
1.7% |
| Hypokalaemia |
1.6% |
| Hyperlipidaemia |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Blood Cholesterol Increased |
1.4% |
| Asthma |
1.3% |
| Myocardial Ischaemia |
1.3% |
|
| Vomiting |
9.5% |
| Syncope |
8.9% |
| Weight Decreased |
8.2% |
| Vertigo |
6.3% |
| Renal Failure Acute |
5.7% |
| Thrombocytopenia |
5.7% |
| Urticaria |
5.7% |
| Diabetic Complication |
5.1% |
| Hypoglycaemia |
5.1% |
| Pyrexia |
5.1% |
| Fatigue |
4.4% |
| Renal Impairment |
4.4% |
| Wheezing |
3.8% |
| Drug Ineffective |
3.2% |
| Hypertension |
3.2% |
| Interstitial Lung Disease |
3.2% |
| Melaena |
3.2% |
| Pain In Extremity |
3.2% |
| Pleural Effusion |
3.2% |
| Rash |
3.2% |
|
| Interacting |
| Product Used For Unknown Indication |
44.4% |
| Psychotic Disorder |
33.3% |
| Hypercholesterolaemia |
11.1% |
| Hypertension |
11.1% |
|
| Loss Of Consciousness |
33.3% |
| Renal Failure Acute |
33.3% |
| Respiratory Disorder |
33.3% |
|
